Transforming Urine Specimen Processing: Copan's UriVerse™
In a significant advance for laboratory automation, Copan Diagnostics has unveiled the UriVerse™, a groundbreaking fully automated system designed specifically for the handling of urine specimens. This innovative launch took place at the Association for Diagnostics Laboratory Medicine (ADLM) Clinical Lab Expo in Chicago, highlighting the company’s commitment to revolutionizing laboratory processes.
Key Features of UriVerse™
UriVerse™ represents a leap forward in the automation of urine specimen processing, performing critical pre-analytical tasks that are traditionally conducted manually. The system automates several crucial steps:
- - De-capping: It efficiently removes caps from specimen containers.
- - Aliquoting: UriVerse™ can transfer urine into up to nine secondary tubes, significantly speeding up the aliquoting process.
- - Barcode Labeling: Each aliquoted specimen is automatically labeled, minimizing the potential for human error.
- - Re-capping: After aliquoting, the device ensures that all secondary tubes are properly capped, ready for the next phase of testing.
With its vision-guided technology, UriVerse™ accurately identifies containers, allowing for automated decapping without manual interference. This reduces the chances of mistakes, which is critical in a laboratory setting where precision is paramount.
Efficiency and Consistency in Laboratories
Urine specimens account for a substantial volume of laboratory tests, often resulting in a high workload for staff. Traditionally, the process of aliquoting can be tedious and error-prone, but UriVerse™ streamlines these operations, reducing hands-on time by automating labor-intensive tasks. Laboratories can anticipate an increase in throughput and improved consistency, supporting better overall efficiency. This is particularly important as testing demands continue to rise, especially in critical areas such as chemistry and toxicology.
Fabrizio Mazzocchi, CEO of Copan Diagnostics, emphasized the importance of this innovation: “With UriVerse™, we are providing a powerful solution that addresses the pressing challenges laboratories face today. Our commitment to enhancing laboratory automation is reflected in this technology, which will undoubtedly support the growing demand for urine testing while also improving the accuracy and speed of results.”
The device efficiently manages the substantial volumes of urine specimens that labs handle daily, minimizing the physical strain on laboratory personnel and enhancing workflow. Given the trend towards increased testing and the need for faster turnaround times, UriVerse™ integrates seamlessly into existing laboratory setups, supporting enhanced specimen traceability and operational flow.
Availability in the Market
Since its successful introduction at the ADLM event, UriVerse™ is now available for procurement in the United States directly through Copan Diagnostics. This launch adds to Copan's existing portfolio of automation solutions, which already includes renowned products like WASP® and WASPLab®, further cementing Copan’s role as a leader in laboratory automation and specimen management.
As Copan continues to innovate within the realm of microbiology and lab automation, the introduction of UriVerse™ is a timely response to the contemporary demands of diagnostic laboratories. With advanced features designed to reduce error rates and improve efficiency, laboratories can better meet the challenges posed by increasing workloads and urgent testing requirements.
About Copan Diagnostics, Inc.
Copan Diagnostics is a key player in the global market as a manufacturer of collection and transport systems. The company's innovative technologies such as FLOQSwabs®, ESwab®, and UTM® Universal Transport Medium™ have transformed specimen collection and laboratory automation. Copan remains devoted to enhancing healthcare outcomes by facilitating more efficient laboratory operations.
For more information about UriVerse™ and other innovative solutions offered by Copan, interested parties can visit
copanusa.com.